Tyra Biosciences Inc
(TYRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | |
| Operating Expenses | 2,332 |
| Operating Income | -2,332 |
| Other Income | -7 |
| Pre-tax Income | -2,339 |
| Net Income Continuous | -2,339 |
| Net Income | $-2,339 |
| EPS Basic Total Ops | -1.47 |
| EPS Basic Continuous Ops | -1.47 |
| EPS Diluted Total Ops | -1.47 |
| EPS Diluted Continuous Ops | -1.47 |
| EBITDA(a) | $-2,332 |